Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 14822-14823 [E8-5496]
Download as PDF
<![CDATA[
14822
Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
jlentini on PROD1PC65 with NOTICES
Time and Date: 9 a.m.–2:45 p.m., April 23,
2008.
Place: Marriott Crystal City, 1999 Jefferson
Davis Highway, Arlington, VA 22202. Via
Teleconference—For toll-free access, please
dial 888–791–1856. Participant Pass Code
49328.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation the
Director, Centers for Disease Control and
Prevention, are authorized under sections
301 and 308 of the Public Health Service Act
to conduct directly or by grants or contracts,
research, experiments, and demonstrations
relating to occupational safety and health and
to mine health. The Board of Scientific
Counselors shall provide guidance to the
Director, National Institute for Occupational
Safety and Health on research and prevention
programs. Specifically, the Board shall
provide guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and disseminating
results. The Board shall evaluate the degree
to which the activities of the National
Institute for Occupational Safety and Health:
(1) Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters to be Discussed: Agenda items
include a report from the Director of NIOSH;
NIOSH Implementation of the National
Academies of Science Program
Recommendations; Occupational Safety and
Health Training Recommendations; Update
on Enhancing the Utility of NIOSH
Information Products; Presentation on
NIOSH Work-Related Stress Research and
Future Meetings and Closing Remarks.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Roger Rosa, Executive Secretary, BSC,
NIOSH, CDC, 395 E Street, SW., Suite 9200,
Patriots Plaza Building, Washington, DC
20201, telephone (202) 245–0655, fax (202)
245–0664.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control/ Initial Review Group,
(NCIPC/IRG)
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned review group:
Times and Date: 1 p.m.–1:30 p.m., April
15, 2008 (Open). 1:30 p.m.–5 p.m., April 15,
2008 (closed).
Place: Teleconference.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of cooperative agreement
applications submitted in response to Fiscal
Year 2008 Requests for Applications related
to the following individual research
announcement: CE08–006, Feasibility of
Acute Concussion Management in the
Emergency Department.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: J.
Felix Rogers, PhD, M.P.H., NCIPC/Extramural
Research Program Office, CDC, 4770 Buford
Highway, NE., M/S F62, Atlanta, Georgia
30341–3724, Telephone (770) 488–4334.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 13, 2008.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8–5498 Filed 3–18–08; 8:45 am]
Dated: March 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–5491 Filed 3–18–08; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Aug<31>2005
16:50 Mar 18, 2008
Jkt 214001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Board Meeting Times and Dates: 8:30 a.m.–
5 p.m., April 7, 2008. 8:30 a.m.–5 p.m., April
8, 2008. 8:30 a.m.–3 p.m., April 9, 2008.
Public Comment Times and Dates: 5 p.m.–
6 p.m., April 7, 2008. 7:30 p.m.–8:30 p.m.,
April 8, 2008.
Place: Crowne Plaza Tampa East, 10221
Princess Palm Avenue, Tampa, FL 33610,
Telephone (813) 623–6363, Fax (813) 246–
7113.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 75 to 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
E:\FR\FM\19MRN1.SGM
19MRN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The topics for the
Subcommittee meeting will include a Review
of Individual Dose Reconstructions and
future Subcommittee Plans and Actions. The
agenda for the Advisory Board meeting
includes: NIOSH Program Status Report
Update; Special Exposure Class (SEC)
Petition Evaluation Reports for: Texas City
Chemicals, Inc., SAM Laboratories, Kellex/
Pierpont, Massachusetts Institute of
Technology, Area IV of the Santa Susana
Field Laboratory, Horizons, Inc., and NUMEC
Parks; Quality assurance and quality control
processes by NIOSH; Ethics training for
Board members; Procedures Work Group:
summary report and full presentation on new
matrix format; SEC Petition Status Updates:
Sandia National Laboratory-Livermore,
Chapman Valve, Hanford, Blockson,
Bethlehem Steel; Department of Labor (DOL)
Update; Department of Energy (DOE) Update;
Work Group reports; Subcommittee on Dose
Reconstruction Report; Board Future Plans
and Schedules.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted
according the policy provided below. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that
announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
VerDate Aug<31>2005
16:50 Mar 18, 2008
Jkt 214001
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Christine Branche, PhD, Executive Secretary,
NIOSH, CDC, 395 E Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513)
533–6800, Toll Free 1–(800) 35–NIOSH, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 12, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–5496 Filed 3–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Practice-Based
Research Networks.
Date: April 21, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Laurie Friedman Donze,
PhD, Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
14823
Dated: March 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5467 Filed 3–18–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Commission on Digestive
Diseases.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National
Commission on Digestive Diseases.
Date: May 16, 2008.
Time: 4 p.m. to 7 p.m.
Agenda: Update on burden of disease
report; overview of Commission and key
elements of final report and general
discussion. Pre-registration is required;
instructions will be available on the
Commission’s Web site at https://www2.
niddk.nih.gov/AboutNIDDKlCommittees
AndWorkingGroups/NCDD/default.htm.
Place: Westin San Diego, 400 West
Broadway, Topaz Room, San Diego, CA
92101.
Contact Person: Stephen P. James,
MD, Director, Division of Digestive
Diseases & Nutrition, National Institute
of Diabetes and Digestive and Kidney
Diseases, NIH, 6707 Democracy Blvd.,
Rm. 677, Bethesda, MD 20892–5450,
301–594–7680,
natlcommdd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5463 Filed 3–18–08; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 73, Number 54 (Wednesday, March 19, 2008)]
[Notices]
[Pages 14822-14823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5496]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Board Meeting Times and Dates: 8:30 a.m.-5 p.m., April 7, 2008.
8:30 a.m.-5 p.m., April 8, 2008. 8:30 a.m.-3 p.m., April 9, 2008.
Public Comment Times and Dates: 5 p.m.-6 p.m., April 7, 2008.
7:30 p.m.-8:30 p.m., April 8, 2008.
Place: Crowne Plaza Tampa East, 10221 Princess Palm Avenue,
Tampa, FL 33610, Telephone (813) 623-6363, Fax (813) 246-7113.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC.
NIOSH implements this responsibility for CDC. The charter was
issued on August 3, 2001, renewed at appropriate intervals, and will
expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and
[[Page 14823]]
on whether there is reasonable likelihood that such radiation doses
may have endangered the health of members of this class.
Matters to be Discussed: The topics for the Subcommittee meeting
will include a Review of Individual Dose Reconstructions and future
Subcommittee Plans and Actions. The agenda for the Advisory Board
meeting includes: NIOSH Program Status Report Update; Special
Exposure Class (SEC) Petition Evaluation Reports for: Texas City
Chemicals, Inc., SAM Laboratories, Kellex/Pierpont, Massachusetts
Institute of Technology, Area IV of the Santa Susana Field
Laboratory, Horizons, Inc., and NUMEC Parks; Quality assurance and
quality control processes by NIOSH; Ethics training for Board
members; Procedures Work Group: summary report and full presentation
on new matrix format; SEC Petition Status Updates: Sandia National
Laboratory-Livermore, Chapman Valve, Hanford, Blockson, Bethlehem
Steel; Department of Labor (DOL) Update; Department of Energy (DOE)
Update; Work Group reports; Subcommittee on Dose Reconstruction
Report; Board Future Plans and Schedules.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted according the policy provided below. Any written
comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the
meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Christine Branche, PhD,
Executive Secretary, NIOSH, CDC, 395 E Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513) 533-6800, Toll Free 1-(800)
35-NIOSH, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 12, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-5496 Filed 3-18-08; 8:45 am]
BILLING CODE 4163-18-P
